Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Polyrizon Ltd (PLRZ)

Polyrizon Ltd (PLRZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,927
  • Shares Outstanding, K 1,042
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,550 K
  • EBIT $ 0 M
  • EBITDA $ -1 M
  • 60-Month Beta -4.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.88 +164.24%
on 11/26/25
18.20 -58.19%
on 12/04/25
+3.53 (+86.52%)
since 11/24/25
3-Month
2.88 +164.24%
on 11/26/25
18.20 -58.19%
on 12/04/25
+1.19 (+18.54%)
since 09/24/25
52-Week
2.88 +164.24%
on 11/26/25
4,200.00 -99.82%
on 12/30/24
-3,112.39 (-99.76%)
since 12/24/24

Most Recent Stories

More News
This Former Penny Stock Just Doubled for the Second Time This Week. Should You Chase the Rally Here?

Polyrizon shares have skyrocketed this week on breakthrough preclinical data for its naloxone hydrogen. But PLRZ stock remains a risky proposition heading into 2026.

PLRZ : 7.61 (+5.26%)
Polyrizon Reports Positive Pre-Clinical Results for PL-14 Allergy Blocker

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

PLRZ : 7.61 (+5.26%)
Polyrizon Ltd. Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs in Preparation for Upcoming Clinical Trial

Polyrizon Ltd. appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs to advance clinical trials.Quiver AI SummaryPolyrizon Ltd., a biotech company focused on innovative intranasal...

PLRZ : 7.61 (+5.26%)
Polyrizon Partners with Eurofins CDMO for Clinical Trial Material Production of PL-14 Allergy Blocker

Polyrizon partners with Eurofins CDMO for GMP manufacturing to support its upcoming PL-14 clinical trial in 2025.Quiver AI SummaryPolyrizon Ltd., a biotech company in Israel, has announced a manufacturing...

PLRZ : 7.61 (+5.26%)
Polyrizon's Retail Following Booms As Biotech Stock Triples On Manufacturing Deal For Allergy Blocker Trial

This collaboration will supply clinical trial material for Polyrizon’s experimental allergy blocker, PL-14, which is set to enter clinical trials in 2025.

PLRZ : 7.61 (+5.26%)
Polyrizon Ltd. Appoints Asaf Azulay as VP of Regulatory Affairs and Quality Assurance

Polyrizon appoints Asaf Azulay as VP of Regulatory Affairs, enhancing compliance and advancing innovative intranasal hydrogel solutions.Quiver AI SummaryPolyrizon Ltd., a biotech company focused on developing...

PLRZ : 7.61 (+5.26%)
Polyrizon Ltd. Signs Manufacturing Agreement with Eurofins CDMO to Support PL-14 Clinical Trial Preparation

Polyrizon partners with Eurofins CDMO for manufacturing PL-14 clinical trial material, enhancing preparation for 2025 trial.Quiver AI SummaryPolyrizon Ltd., a biotech company focused on developing intranasal...

PLRZ : 7.61 (+5.26%)

Business Summary

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

See More

Key Turning Points

3rd Resistance Point 9.10
2nd Resistance Point 8.54
1st Resistance Point 8.08
Last Price 7.61
1st Support Level 7.06
2nd Support Level 6.50
3rd Support Level 6.04

See More

52-Week High 4,200.00
Fibonacci 61.8% 2,596.70
Fibonacci 50% 2,101.44
Fibonacci 38.2% 1,606.18
Last Price 7.61
52-Week Low 2.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar